NEW: US FDA CDC see early signal of Pfizer bivalent Covid-19 shot’s link to stroke

A safety monitoring system flagged that US drugmaker Pfizer Inc and German partner BioNTech’s updated Covid-19 shot could be linked to a type of brain stroke in older adults, according to preliminary data analyzed by U.S. health authorities.

The US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) said on Friday that a CDC vaccine database had uncovered a possible safety issue in which people 65 and older were more likely to have an ischemic stroke 21 days after receiving the Pfizer/BioNTech bivalent shot, compared with days 22-44.

An ischemic stroke, also known as brain ischemia, is caused by blockages in arteries that carry blood to the brain.

The FDA and CDC said that other large studies, the CDC’s Vaccine Adverse Event Reporting System, other countries’ databases and Pfizer-BioNTech’s databases had not flagged this safety issue, adding that it requires more investigation.

“Although the totality of the data currently suggests that it is very unlikely that the signal in VSD (Vaccine Safety Datalink) represents a true clinical risk, we believe it is important to share this information with the public,” the health authorities said. – Reuters

Related Posts

President Mnangagwa arrives at Sanganai Expo in Masvingo

Nqobile Bhebhe in Masvingo President Mnangagwa has arrived to officially open the 19th edition of the Sanganai/Hlanganani/Dzimbahwe World Tourism Expo in Masvingo. The high-profile showcase provides the country with a…

Zimbabwe courts global tourism investment as President opens Sanganai Expo

President Mnangagwa is today expected to officially open the 19th edition of the Sanganai/Hlanganani World Tourism Expo at the Gymkhana Events and Conference Centre in Masvingo. The country’s premier tourism…

Leave a Reply

Your email address will not be published. Required fields are marked *